Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1457.40
5.05 (0.35%)
< Home < Back

Cipla - Quaterly Results

Date: 29-10-2024
The revenue for the September 2024 quarter is pegged at Rs. 47750.30 millions, about 12.77% up against Rs. 42344.40 millions recorded during the year-ago period.A good growth in profit of 28.68% reported to Rs. 11781.60  millions over Rs. 9155.40 millions of corresponding previous quarter.The company reported a good operating profit of 17271.80 millions compared to 14304.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 47750.30 42344.40 12.77 92760.80 81563.40 13.73 165743.40 143453.40 15.54
Other Income 2891.40 2050.90 40.98 5026.60 3630.70 38.45 10706.60 4567.90 134.39
PBIDT 17271.80 14304.70 20.74 33005.60 26646.60 23.86 55548.10 38096.80 45.81
Interest 30.00 66.10 -54.61 80.70 69.20 16.62 202.50 222.70 -9.07
PBDT 17241.80 14238.60 21.09 32924.90 26577.40 23.88 55345.60 36015.10 53.67
Depreciation 1457.10 1798.10 -18.96 2835.70 3157.60 -10.19 5875.90 5959.10 -1.40
PBT 15784.70 12440.50 26.88 30089.20 23419.80 28.48 49469.70 30056.00 64.59
TAX 4003.10 3285.10 21.86 7748.20 6275.60 23.47 12327.80 8615.40 43.09
Deferred Tax -64.20 -13.00 393.85 101.70 -102.50 -199.22 60.90 -400.90 -115.19
PAT 11781.60 9155.40 28.68 22341.00 17144.20 30.31 37141.90 21440.60 73.23
Equity 1615.10 1614.70 0.02 1615.10 1614.70 0.02 1614.70 1614.30 0.02
PBIDTM(%) 36.17 33.78 7.07 35.58 32.67 8.91 33.51 26.56 26.20